Decision on to buy or sell Fermenta-Biotech-Ltd BSE Stocks gets more clarity after reading these charts. And the benchmark S&P BSE SENSEX was at 51,703.8 (down 0.8%). With plans to begin their third stage of clinical trials next month, COVAXIN has proven effective in the first two phases. Hyderabad-based vaccine manufacturing company Bharat Biotech on Wednesday announced phase 3 clinical results of its indigenously-made Covid-19 vaccine candidate, Covaxin. Bharat Biotech is a leading manufacturer of vaccines and a leading biotech company in India. Find the latest BHARAT ELECTRONICS (BEL.NS) stock quote, history, news and other vital information to help you with your stock trading and investing. Get all Indian company stock quotes listed in the share market. 150,746,144. An additional interim analysis is planned for 87 … Bharat Electronics Ltd. share price forecast The 23 reports from 6 analysts offering long term price targets for Bharat Electronics Ltd. have an average target of 141.83. Decision on to buy or sell Fermenta-Biotech-Ltd BSE Stocks gets more clarity after reading these charts. Slightly overvalued with worrying balance sheet. of warrants As a % of Total No. Over the last 30 days, the BHARAT 22 ETF - ICICI PRUDENTIAL AMC share price is up 8.0%. They expressed gratitude to PM Modi for reposing his trust in the indigenously developed COVID-19 vaccine. Reliance Industries Live NSE/BSE Share Price: Get Reliance Industries Stock Price details, News, Financial Results, Stock Charts, Returns, Research Reports and more The consensus estimate represents a downside of -3.52% from the last price of 147.00. How has Bharat Parenterals's share price performed over time and what events caused price changes? Bharat Biotech has its manufacturing facility situated at Genome Valley, Hyderabad, India. Our mission is to deliver affordable, safe and high-quality vaccines and bio-therapeutics that help people prevail over diseases. As of July 2020, the company has over 700 employees and has a presence worldwide.. HYDERABAD: Hyderabad-based vaccine-maker Bharat Biotech will be leading a project sanctioned by the Council of Scientific and Industrial Research (CSIR) to … Modi takes Covid-19 … Hyderabad: The promoters of Indian vaccine innovator Bharat Biotech International Ltd (BBIL) have acquired the holding of private equity giant ICICI Venture for around Rs 130 crore, valuing the company at over Rs 1,300 crore. They have been working on the COVID-19 vaccine, named COVAXIN. Bharat Biotech International Limited (BBIL) has welcomed Prime Minister Narendra Modi’s gesture for taking the first dose of its covid vaccine, Covaxin. bse rss RSS stands for Really Simple Syndication. Bharat Biotech's vaccine showed 81% efficacy in preventing symptomatic COVID-19 in an interim analysis of a late-stage trial in India, it said on Wednesday, a major … Bharat Biotech has raised $14.10 m in total funding. Bharat Biotech … The total volume of shares traded was 0.0 m. Overall, the broader S&P BSE HEALTHCARE Index was down by 0.9%. Raches Ella, head of business development at Hyderabad-based Bharat Biotech, said the company will manufacture the vaccine, conduct clinical trials and prepare to produce almost 300 million doses of … Check out the latest ideas and forecasts on BHARAT IMMUNOLOGICALS & BIOLOG from our top authors — they share predictions and technical outlook of the market. of warrants As a % of Total No. The developers of the drug, the Hyderabad-based firm Bharat Biotech in collaboration with India’s National Institute of Virology and Indian Council of Medical Research, have received approval from the drug control authorities to conduct human clinical trials of the vaccine christened ‘COVAXIN’. And over the last one year, BHARAT 22 ETF - ICICI PRUDENTIAL AMC share … Get Bharat Immunological & Biologicals Corporation Ltd. live share price, historical charts, volume, market capitalisation, market performance, reports and other company details.